EO2002
Asset
Magnetic human corneal endothelial cells replace lost endothelial cells to restore corneal function and reduce edema.
- Stage
- Phase 2
- Modality
- Cell therapy
- Target
- Not known
- 10
- Indications
- 1
- Trial
- 1
- Developer
Indications
10Corneal edema
Phase 2, Recruiting, NCT07729137, clinicaltrials.gov, 13 Oct 2026
Corneal endothelial cell loss
Phase 2, Recruiting, NCT07729137, clinicaltrials.gov, 13 Oct 2026
Corneal endothelial decompensation
Phase 2, Recruiting, NCT07729137, clinicaltrials.gov, 13 Oct 2026
7 more
In the full profile
- Owner and partners1
- Trials1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.